ANDREASI, VALENTINA
 Distribuzione geografica
Continente #
EU - Europa 2.183
NA - Nord America 1.741
AS - Asia 1.719
SA - Sud America 270
AF - Africa 41
OC - Oceania 4
Totale 5.958
Nazione #
US - Stati Uniti d'America 1.655
RU - Federazione Russa 1.271
SG - Singapore 578
CN - Cina 559
IT - Italia 287
HK - Hong Kong 242
BR - Brasile 219
SE - Svezia 166
VN - Vietnam 148
DE - Germania 114
FR - Francia 85
GB - Regno Unito 79
IN - India 57
CA - Canada 56
FI - Finlandia 56
JP - Giappone 28
ES - Italia 24
NL - Olanda 23
AR - Argentina 22
BD - Bangladesh 20
MX - Messico 19
PL - Polonia 19
AT - Austria 17
PK - Pakistan 13
TR - Turchia 13
ZA - Sudafrica 12
IE - Irlanda 11
EC - Ecuador 9
NP - Nepal 9
MA - Marocco 8
IQ - Iraq 7
PH - Filippine 7
CO - Colombia 5
ID - Indonesia 5
KE - Kenya 5
LT - Lituania 5
TN - Tunisia 5
UA - Ucraina 5
UZ - Uzbekistan 5
AU - Australia 4
BE - Belgio 4
BO - Bolivia 4
CH - Svizzera 4
IL - Israele 4
SA - Arabia Saudita 4
CL - Cile 3
JO - Giordania 3
PT - Portogallo 3
PY - Paraguay 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
JM - Giamaica 2
KR - Corea 2
KZ - Kazakistan 2
MD - Moldavia 2
MY - Malesia 2
PA - Panama 2
PE - Perù 2
PS - Palestinian Territory 2
TW - Taiwan 2
VE - Venezuela 2
AZ - Azerbaigian 1
BH - Bahrain 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EG - Egitto 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
MU - Mauritius 1
NG - Nigeria 1
RS - Serbia 1
SC - Seychelles 1
TG - Togo 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 5.958
Città #
Singapore 360
Ashburn 325
Dallas 257
Moscow 251
Hong Kong 235
San Jose 168
Shanghai 121
Beijing 118
Milan 93
New York 91
Los Angeles 84
Hefei 67
Lauterbourg 53
Ho Chi Minh City 51
Boardman 40
São Paulo 37
Hanoi 35
Orem 33
Munich 31
London 28
Helsinki 27
Santa Clara 27
Lawrence 26
Princeton 26
Tokyo 26
Montreal 22
Nuremberg 22
Turku 22
Washington 22
Chennai 20
Rome 18
The Dalles 18
Cesano Boscone 16
Toronto 16
Columbus 15
Frankfurt am Main 15
Brooklyn 14
Manchester 14
Atlanta 13
Chicago 13
Council Bluffs 13
Poplar 13
San Francisco 13
Warsaw 13
Boston 12
Denver 12
Dublin 11
Seattle 11
Falkenstein 10
Guangzhou 10
Mexico City 10
Houston 9
Phoenix 9
Stockholm 9
Amsterdam 8
Johannesburg 8
Mumbai 8
Romagnano Sesia 8
Ankara 7
Kathmandu 7
Rio de Janeiro 7
Valencia 7
Da Nang 6
Lappeenranta 6
New Delhi 6
Pune 6
Barnet 5
Belo Horizonte 5
Dhaka 5
Haiphong 5
Jinan 5
Nairobi 5
Tabira 5
Baie-D'Urfé 4
Biên Hòa 4
Brasília 4
Brescia 4
Olgiate Olona 4
Ottawa 4
Pittsburgh 4
Portland 4
Shenzhen 4
Sydney 4
São Gonçalo 4
Tashkent 4
Thái Bình 4
Verona 4
Vienna 4
Wroclaw 4
Bologna 3
Bolzano 3
Borgosesia 3
Brussels 3
Bursa 3
Bắc Ninh 3
Can Tho 3
Casablanca 3
Charlotte 3
Curitiba 3
Dalian 3
Totale 3.241
Nome #
ROLE OF CHROMOGRANIN A-DERIVED FRAGMENTS AND OTHER BIOMARKERS IN PANCREATIC NEOPLASMS: FOCUS ON NEUROENDOCRINE TUMORS 177
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours 172
3D Primary Cell Culture: A Novel Preclinical Model For Pancreatic Neuroendocrine Tumors (PanNETs) 160
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 157
Clinical and economic validation of grade B postoperative pancreatic fistula subclassification 140
68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks 138
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 130
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 121
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms 114
Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic features 114
Could Glycated Hemoglobin be Leakage Predictor in Sleeve Gastrectomy? A Retrospective Observational Study on 4233 Patients 112
A preoperative clinical risk score including c-reactive protein predicts histological tumor characteristics and patient survival after surgery for sporadic non-functional pancreatic neuroendocrine neoplasms: An international multicenter cohort study 112
Circulating Neuroendocrine Gene Transcripts (NETest): A Postoperative Strategy for Early Identification of the Efficacy of Radical Surgery for Pancreatic Neuroendocrine Tumors 112
The role of acinar content at pancreatic resection margin in the development of postoperative pancreatic fistula and acute pancreatitis after pancreaticoduodenectomy 112
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 111
ASO Visual Abstract: Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Nonfunctioning Pancreatic Neuroendocrine Tumors 108
Preoperative predictive factors of laparoscopic distal pancreatectomy difficulty 103
ASO Visual Abstract: Long-Term Survivors After Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 102
Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 102
Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs) 102
CT-derived radiomic features to discriminate histologic characteristics of pancreatic neuroendocrine tumors 100
Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification 98
Critical appraisal of the adequacy of surgical indications for non-functioning pancreatic neuroendocrine tumours 97
Either High or Low Risk: The Acinar Score at the Resection Margin Dichotomizes the Risk Spectrum of Pancreas-specific Complications After Pancreatoduodenectomy 96
Management of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors: Limitations to apply guidelines into real life 95
Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Non-Functioning Pancreatic Neuroendocrine Tumors 93
How to Select Patients Affected by Neuroendocrine Neoplasms for Surgery 93
Multidisciplinary management of patients diagnosed with von Hippel-Lindau disease: A practical review of the literature for clinicians 93
Diagnostic work-up and surgical management of insulinoma: A retrospective analysis from a tertiary referral center 92
Clinical and Financial Validation of the International Study Group for Pancreatic Surgery (ISGPS) Definition of Post-Pancreatectomy Acute Pancreatitis (PPAP): International Multicenter Prospective Study 91
Non functional pancreatic neuroendocrine tumors 90
A systematic review and meta-analysis on the role of omental or falciform ligament wrapping during pancreaticoduodenectomy 90
Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3 90
Evaluation of cost-effectiveness among open, laparoscopic and robotic distal pancreatectomy: A systematic review and meta-analysis 88
Pancreatectomy with venous vascular resection for pancreatic cancer: Impact of types of vein resection on timing and pattern of recurrence 87
New Surgical Strategies 87
Diagnosis and Treatment of Pancreatic Neuroendocrine Tumors: How to Deal with them in Clinical Practice? 85
Disease-free survival as a measure of overall survival in resected pancreatic endocrine neoplasms 85
Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis 84
Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: An endearing tool for preoperative risk assessment 84
Is the Real Prevalence of Pancreatic Neuroendocrine Tumors Underestimated? A Retrospective Study on a Large Series of Pancreatic Specimens 83
Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma 83
Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms? 81
Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence? 78
Infiltrative Growth Predicts the Risk of Recurrence After Surgery in Well-Differentiated Non-Functioning Pancreatic Neuroendocrine Tumors 78
Prognostic significance of nodal micrometastases of non-functioning pancreatic neuroendocrine tumours 75
Outcomes after distal pancreatectomy for neuroendocrine neoplasms: a retrospective comparison between minimally invasive and open approach using propensity score weighting 74
EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs) 73
Exploring definitions of graft pancreatitis following pancreas transplantation: A scoping review 68
Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours 67
Dual tracer 68ga-dotatoc and 18f-fdg pet improve preoperative evaluation of aggressiveness in resectable pancreatic neuroendocrine neoplasms 67
Local treatment for focal progression in metastatic neuroendocrine tumors 64
Histopathological and Immunophenotypic Changes of Pancreatic Neuroendocrine Tumors after Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT) 63
Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors 61
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 60
Role of Preoperative High-Resolution Manometry in the Identification of Patients at High Risk of Postoperative GERD Symptoms 1 Year After Sleeve Gastrectomy 59
Sporadic non-functioning pancreatic neuroendocrine tumours: multicentre analysis 58
Role of chromogranin A-derived fragments after resection of nonfunctioning pancreatic neuroendocrine tumors 53
Update on gastroenteropancreatic neuroendocrine tumors 53
Surgical Principles in the Management of Pancreatic Neuroendocrine Neoplasms 53
Implications of increased serum amylase after pancreaticoduodenectomy: toward a better definition of clinically relevant postoperative acute pancreatitis 52
Evaluation of factors predicting loss of benefit provided by laparoscopic distal pancreatectomy compared to open approach 51
Safety and cost-effectiveness of immediate right hemicolectomy versus active surveillance for well-differentiated appendiceal neuroendocrine tumors 1-2 cm in size: a Markov decision analysis 50
Prognostic role of examined and positive lymph nodes after distal pancreatectomy for non-functioning neuroendocrine neoplasms 50
Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management 49
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy 47
Gender and Age as Preoperative Predictors of Early Disease Progression in Patients Undergoing Surgery for Pancreatic Neuroendocrine Tumors with Liver Metastases 45
Reply to Letter to the Editor: Role of Preoperative High-Resolution Manometry in the Identification of Patients at High Risk of Postoperative GERD Symptoms 1 Year After Sleeve Gastrectomy 44
Preoperative predictors of new-onset diabetes mellitus following distal pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors 42
Mesenteric paraganglioma mimicking nodal metastasis of an occult small intestinal neuroendocrine tumor 1
Totale 6.099
Categoria #
all - tutte 28.023
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.023


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202238 0 1 1 6 4 2 10 1 6 2 2 3
2022/2023303 59 50 23 19 12 44 26 29 17 8 8 8
2023/2024533 19 25 72 54 61 111 6 48 4 13 30 90
2024/20251.307 119 45 47 52 65 125 253 171 138 88 95 109
2025/20263.896 284 241 243 526 428 155 370 333 1.134 182 0 0
Totale 6.099